COYA
Coya Therapeutics, Inc.
5.20$
+2.8%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | -97.9% | +2,600.5% | -100.0% | – | +13,111.3% | -36.6% | +2,078.4% | +11.1% | -93.7% | -2.9% | – | |
| – | +1.1% | +95.0% | +45.5% | -51.3% | -12.9% | +169.1% | -99.9% | +0.0% | -76,129.2% | – | – | – | |
| – | – | -168.6% | – | – | – | – | – | +2,169.1% | +11.3% | -93.7% | -2.9% | – | |
| – | +13.2% | +75.5% | +44.4% | -51.3% | -12.9% | +169.1% | +70,154.1% | -99.9% | +130.2% | -38.8% | +22.5% | – | |
| – | +21.0% | +2.6% | -14.4% | +6.3% | -3.7% | +26.9% | +107,059.5% | -99.9% | +27.9% | +15.7% | -40.4% | – | |
| – | +30.7% | -4.1% | -15.2% | +6.3% | -3.7% | +26.9% | +141.5% | -16.7% | +82.5% | -21.0% | -7.6% | – | |
| – | – | -402.1% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -353.9% | – | – | – | – | – | – | – | – | – | – | |
| – | +1,459.1% | -105.0% | – | – | – | – | – | – | – | – | – | – | |
| – | – | -499.1% | – | – | – | – | – | – | – | – | – | – | |
| – | – | -370.5% | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.